Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The daily Top 10 COVID papers


  Free Subscription

Articles published in Eur J Epidemiol

Retrieve available abstracts of 29 articles:
HTML format

Single Articles

    December 2020
  1. LEVIN AT, Hanage WP, Owusu-Boaitey N, Cochran KB, et al
    Assessing the age specificity of infection fatality rates for COVID-19: systematic review, meta-analysis, and public policy implications.
    Eur J Epidemiol. 2020;35:1123-1138.
    PubMed     Abstract available

    November 2020
  2. GOMEZ-OCHOA SA, Franco OH
    COVID-19: facts and failures, a tale of two worlds.
    Eur J Epidemiol. 2020;35:991-994.

  3. CATALANO R, Casey JA, Bruckner TA, Gemmill A, et al
    Non-COVID-19 deaths after social distancing in Norway.
    Eur J Epidemiol. 2020;35:1021-1024.
    PubMed     Abstract available

  4. HANAGE WP, Testa C, Chen JT, Davis L, et al
    COVID-19: US federal accountability for entry, spread, and inequities-lessons for the future.
    Eur J Epidemiol. 2020;35:995-1006.
    PubMed     Abstract available

  5. MILLS EHA, Moller AL, Gnesin F, Zylyftari N, et al
    National all-cause mortality during the COVID-19 pandemic: a Danish registry-based study.
    Eur J Epidemiol. 2020;35:1007-1019.
    PubMed     Abstract available

  6. HUANG J, Teoh JY, Wong SH, Wong MCS, et al
    The potential impact of previous exposure to SARS or MERS on control of the COVID-19 pandemic.
    Eur J Epidemiol. 2020;35:1099-1103.
    PubMed     Abstract available

    August 2020
  7. NADLER P, Wang S, Arcucci R, Yang X, et al
    An epidemiological modelling approach for COVID-19 via data assimilation.
    Eur J Epidemiol. 2020;35:749-761.
    PubMed     Abstract available

  8. TANERI PE, Gomez-Ochoa SA, Llanaj E, Raguindin PF, et al
    Anemia and iron metabolism in COVID-19: a systematic review and meta-analysis.
    Eur J Epidemiol. 2020;35:763-773.
    PubMed     Abstract available

  9. PALAMENGHI L, Barello S, Boccia S, Graffigna G, et al
    Mistrust in biomedical research and vaccine hesitancy: the forefront challenge in the battle against COVID-19 in Italy.
    Eur J Epidemiol. 2020;35:785-788.
    PubMed     Abstract available

  10. DROR AA, Eisenbach N, Taiber S, Morozov NG, et al
    Vaccine hesitancy: the next challenge in the fight against COVID-19.
    Eur J Epidemiol. 2020;35:775-779.
    PubMed     Abstract available

  11. CHIN V, Samia NI, Marchant R, Rosen O, et al
    A case study in model failure? COVID-19 daily deaths and ICU bed utilisation predictions in New York state.
    Eur J Epidemiol. 2020;35:733-742.
    PubMed     Abstract available

  12. BUCKEE CO, Johansson MA
    Individual model forecasts can be misleading, but together they are useful.
    Eur J Epidemiol. 2020;35:731-732.

  13. BARELLO S, Nania T, Dellafiore F, Graffigna G, et al
    'Vaccine hesitancy' among university students in Italy during the COVID-19 pandemic.
    Eur J Epidemiol. 2020;35:781-783.
    PubMed     Abstract available

  14. NADELLA P, Swaminathan A, Subramanian SV
    Forecasting efforts from prior epidemics and COVID-19 predictions.
    Eur J Epidemiol. 2020;35:727-729.
    PubMed     Abstract available

  15. CHOWDHURY R, Luhar S, Khan N, Choudhury SR, et al
    Long-term strategies to control COVID-19 in low and middle-income countries: an options overview of community-based, non-pharmacological interventions.
    Eur J Epidemiol. 2020;35:743-748.
    PubMed     Abstract available

    Containment strategies for the 2019 Novel Coronavirus: flatten the curve or crush it?
    Eur J Epidemiol. 2020;35:789-790.

    June 2020
  17. ORIVE G, Lertxundi U, Barcelo D
    Do we really need to invoke heroic measures for early SARS-CoV-2 outbreak detection?
    Eur J Epidemiol. 2020;35:613-614.

    Good science is good science: we need specialists, not sects.
    Eur J Epidemiol. 2020;35:519-522.

    May 2020
  19. CHOWDHURY R, Heng K, Shawon MSR, Goh G, et al
    Dynamic interventions to control COVID-19 pandemic: a multivariate prediction modelling study comparing 16 worldwide countries.
    Eur J Epidemiol. 2020;35:389-399.
    PubMed     Abstract available

  20. GEMES K, Talback M, Modig K, Ahlbom A, et al
    Burden and prevalence of prognostic factors for severe COVID-19 in Sweden.
    Eur J Epidemiol. 2020;35:401-409.
    PubMed     Abstract available

    April 2020
    Humanistic Epidemiology: Love in the time of cholera, COVID-19 and other outbreaks.
    Eur J Epidemiol. 2020;35:321-324.

  22. STANDL F, Jockel KH, Stang A
    COVID-19 and the need of targeted inverse quarantine.
    Eur J Epidemiol. 2020;35:339-340.

    Vaccine confidence in the time of COVID-19.
    Eur J Epidemiol. 2020;35:325-330.
    PubMed     Abstract available

    The paramount importance of serological surveys of SARS-CoV-2 infection and immunity.
    Eur J Epidemiol. 2020;35:331-333.

  25. SEBASTIANI G, Massa M, Riboli E
    Covid-19 epidemic in Italy: evolution, projections and impact of government measures.
    Eur J Epidemiol. 2020;35:341-345.
    PubMed     Abstract available

    The double burden of disease of COVID-19 in cardiovascular patients: overlapping conditions could lead to overlapping treatments.
    Eur J Epidemiol. 2020;35:335-337.

  27. CHEN Y, Zhang J, Chu X, Xu Y, et al
    Vaccines and the risk of Guillain-Barre syndrome.
    Eur J Epidemiol. 2020;35:363-370.
    PubMed     Abstract available

    January 2020
  28. GUNNES N, Gjessing HK, Bakken IJ, Ghaderi S, et al
    Seasonal and pandemic influenza during pregnancy and risk of fetal death: A Norwegian registry-based cohort study.
    Eur J Epidemiol. 2020 Jan 16. pii: 10.1007/s10654-020-00600.
    PubMed     Abstract available

    December 2019
  29. GHADERI S, Berg-Hansen P, Bakken IJ, Magnus P, et al
    Hospitalization following influenza infection and pandemic vaccination in multiple sclerosis patients: a nationwide population-based registry study from Norway.
    Eur J Epidemiol. 2019 Dec 23. pii: 10.1007/s10654-019-00595.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.